| (Restated) | |||
| 2023 | 2022** | ||
| Note | £ m | £ m | |
Management and other fees | 5 | ||
Carried interest | 5 | ||
Fair value remeasurement of investments | 5 | ||
Other operating income | |||
Total operating income | |||
Personnel expenses | 6 | ( | ( |
Other operating expenses | 7 | ( | ( |
EBITDA* | |||
Depreciation and amortisation expense | 9 | ( | ( |
Finance and other income | 10 | ||
Finance and other expenses | 10 | ( | ( |
Profit before tax* | |||
Tax | 11 | ( | ( |
Profit after tax | |||
| Attributable to: | |||
Equity holders of the parent | |||
£ | £ | ||
Basic and diluted earnings per share | 12 |
| 2023 | 2022 | ||
| Note | £ m | £ m | |
Profit after tax | |||
| Items that may be reclassified to the statement of profit or loss in subsequent years: | |||
Exchange differences on translation of foreign operations | ( | ||
Change in the fair value of hedging instruments | 20 (b) | ( | |
Change in the time value of foreign exchange options | 20 (b) | ||
Reclassifications to the Consolidated Statement of Profit or Loss | 20 (b) | ( | |
Total tax on components of other comprehensive income | 11 (c) | ( | |
Other comprehensive income/(loss) net of tax | ( | ||
Total comprehensive income net of tax | |||
| Total comprehensive income attributable to: | |||
Equity holders of the parent |
| 2023 | 2022 | ||
| Note | £ m | £ m | |
| Assets | |||
| Non-current assets | |||
Property, plant and equipment | 13 | ||
Goodwill and intangible assets | 14 | ||
Carried interest receivable | 15 | ||
Fair value of fund investments | 16 (a), (b) | ||
Trade and other receivables | 16 (a), (f) | ||
Total non-current assets | |||
| Current assets | |||
Consolidated CLO assets* | 16 (a), (d) | ||
Trade and other receivables | 16 (a), (f) | ||
Derivative financial assets | 16 (a), (e) | ||
Other investments | 16 (a), (c) | ||
Cash and cash equivalents | 16 (a), (g) | ||
Term deposits with original maturities of more than three months | 16 (g) | ||
Consolidated CLO cash* | 16 (a), (g) | ||
Total current assets | |||
Total assets | |||
| Liabilities | |||
| Non-current liabilities | |||
Trade and other payables | 17 (a), (b) | ||
Other financial liabilities | 17 (a), (d) | ||
Fair value of consolidated CLO liabilities* | 17 (a), (e) | ||
Lease liabilities | 17 (a),18 | ||
Deferred tax liabilities | 22 | ||
Total non-current liabilities | |||
| Current liabilities | |||
Trade and other payables | 17 (a), (b) | ||
Lease liabilities | 17 (a),18 | ||
Derivative financial liabilities | 17 (a), (g) | ||
Consolidated CLO liabilities* | 17 (a), (e) | ||
Consolidated CLO purchases awaiting settlement* | 17 (a), (f) | ||
Total current liabilities | |||
Total liabilities | |||
Net assets | |||
| Equity | |||
Share capital | 21, 23 (a) | ||
Share premium | 21, 23 (a) | ||
Retained earnings | |||
Other reserves** | 21, 23 (c) | ||
Total equity |
| Share | Share | Other | Retained | Total | ||
| capital | premium | reserves* | earnings | equity | ||
| Note | £ m | £ m | £ m | £ m | £ m | |
At 1 January 2023 | ||||||
Profit for the year | ||||||
Other comprehensive income | ( | |||||
Total comprehensive income | ||||||
Vested share-based payments | 23 (c) | ( | ||||
Share-based payments | 6 (a) | |||||
Share buyback | 23 (c) | ( | ( | |||
Dividends | 24 | ( | ( | |||
At 31 December 2023 |
| Share | Share | Other | Retained | Total | ||
| capital | premium | reserves* | earnings | equity | ||
| Note | £ m | £ m | £ m | £ m | £ m | |
At 1 January 2022 | ||||||
Profit for the year | ||||||
Other comprehensive loss | ( | ( | ||||
Total comprehensive income | ( | |||||
Share-based payments | 6 (a) | |||||
Dividends | 24 | ( | ( | |||
At 31 December 2022 |
| 2023 | 2022 | ||
| Note | £ m | £ m | |
| Cash flows from operating activities | |||
Cash generated from operations | 25 (a) | ||
Tax paid | ( | ( | |
Net cash inflow from operating activities | |||
| Cash flows from investing activities | |||
Investment in term deposits with original maturities of more than three months | 16 (g) | ( | |
Receipts from investments (non-CLO) | |||
Purchase of investments (non-CLO) | ( | ( | |
Purchase of other investments (non-CLO) | 16 (c) | ( | |
Interest received (non-CLO) | |||
Payment for foreign exchange option premium | ( | ||
Investments in non-consolidated CLOs | ( | ||
Cash acquired on consolidation of intermediate fund holding entities | |||
Receipts from investments (consolidated CLOs) | |||
Purchase of investments (consolidated CLOs) | ( | ( | |
Cash movements from the consolidated CLOs | |||
Payments for property, plant and equipment and intangible assets | 13 | ( | ( |
Net cash outflow from investing activities | ( | ( | |
| Cash flows from financing activities | |||
IPO costs | ( | ||
Dividends paid to shareholders of the Company | 24 | ( | ( |
Share buyback | 23 (c) | ( | |
Drawings from related party investors in intermediate fund holding entities | |||
Principal elements of lease payments | ( | ( | |
Drawn funding (consolidated CLOs) | |||
Repayment of CLO borrowings (consolidated CLOs) | ( | ( | |
Cash from/(paid to) CLO investors (consolidated CLOs) | ( | ||
Interest paid (non-CLO) | ( | ( | |
Net cash inflow/(outflow) from financing activities | ( | ||
Net increase/(decrease) in cash and cash equivalents | ( | ||
Total cash and cash equivalents at the beginning of the year | |||
Effect of exchange rate changes on cash and cash equivalents | ( | ||
Total cash and cash equivalents at the end of year | |||
Cash and cash equivalents (for use within the Group) | 16 (g) | ||
Consolidated CLO cash (restricted for use within relevant CLO) | 16 (g) | ||
Total cash and cash equivalents at the end of year |
International accounting standards and interpretations | Effective date |
| Amendments to IAS 1 “Presentation of Financial Statements” and IFRS Practice Statement 2 “Disclosure of | |
Accounting Policies” | 1 January 2023 |
Amendments to IAS 8 “Definition of Accounting Estimates” | 1 January 2023 |
IFRS 17 “Insurance Contracts” | 1 January 2023 |
Amendments to IAS 12 “Deferred Tax Related to Assets and Liabilities Arising from a Single Transaction” | 1 January 2023 |
International Tax Reform – Pillar Two Model Rules – Amendments to IAS 12 | 23 May 2023 |
International accounting standards and interpretations | Effective date |
Amendments to IFRS 16 “Leases”: lease liability in a sale and leaseback | 1 January 2024 |
Amendments to IAS 1: non-current liabilities with covenants and classification of liabilities as current or non-current | 1 January 2024 |
Asset class | Useful life |
Computers, furniture and other | 3 to 6 years |
Leasehold improvements | Over the shorter of their useful economic life or the lease term |
Property right-of-use assets | Over the contractual lease term |
| Bridgepoint interest in | Bridgepoint share | |||
| Name of CLOs | the subordinated notes | of CLO | Consolidation treatment at YE23 | Nature of the entity |
Bridgepoint CLO 1 DAC | 55.2% | 5.0% | Consolidated | Subordinated notes in the residual class |
Bridgepoint CLO 2 DAC | 5.0% | 5.0% | Not consolidated | Subordinated notes in the residual class |
Bridgepoint CLO 3 DAC | 51.0% | 8.9% | Consolidated | Subordinated notes in the residual class |
Bridgepoint CLO IV DAC | 61.0% | 7.0% | Consolidated | Subordinated notes in the residual class |
Bridgepoint CLO V DAC | 51.8% | 5.1% | Consolidated | Subordinated notes in the residual class |
Bridgepoint CLO VI DAC | 50.0% | 50.0% | Consolidated | Warehouse entity |
| Private Equity | Private Credit | Central | Total Core | Total Other | Total Group | |
| Year ended 31 December 2023 | £ m | £ m | £ m | £ m | £ m | £ m |
Management and other fees | 205.0 | 56.5 | 3.8 | 265.3 | – | 265.3 |
Carried interest | 30.0 | – | – | 30.0 | – | 30.0 |
Fair value remeasurement of investments | 17.3 | 8.0 | – | 25.3 | – | 25.3 |
Other operating income | 0.2 | – | – | 0.2 | 0.8 | 1.0 |
Total operating income | 252.5 | 64.5 | 3.8 | 320.8 | 0.8 | 321.6 |
Personnel expenses | (69.3) | (21.3) | (36.0) | (126.6) | (1.0) | (127.6) |
Other operating expenses | (18.3) | (8.8) | (18.0) | (45.1) | (0.1) | (45.2) |
| Underlying EBITDA (excluding exceptional expenses | ||||||
and certain share-based payment expenses) | 164.9 | 34.4 | (50.2) | 149.1 | (0.3) | 148.8 |
Exceptional expenses | (47.7) | |||||
Certain excluded share-based payment expenses | (4.0) | |||||
EBITDA | 97.1 | |||||
Depreciation and amortisation | (18.7) | |||||
Finance and other income and expenses | 7.6 | |||||
Profit before tax | 86.0 |
| (Restated) | (Restated) | (Restated) | ||||
| Private Equity | Private Credit | Central | Total Core | Total Other | Total Group | |
| Year ended 31 December 2022 | £ m | £ m | £ m | £ m | £ m | £ m |
Management and other fees | 187.8 | 50.8 | 2.9 | 241.5 | – | 241.5 |
Carried interest | 24.2 | – | – | 24.2 | – | 24.2 |
Fair value remeasurement of investments | 32.1 | 8.6 | – | 40.7 | – | 40.7 |
Other operating income | 0.2 | – | – | 0.2 | 0.8 | 1.0 |
Total operating income | 244.3 | 59.4 | 2.9 | 306.6 | 0.8 | 307.4 |
Personnel expenses | (67.6) | (21.2) | (35.9) | (124.7) | (1.1) | (125.8) |
Other operating expenses | (16.2) | (8.4) | (17.6) | (42.2) | (0.2) | (42.4) |
| Underlying EBITDA* (excluding exceptional | ||||||
expenses) | 160.5 | 29.8 | (50.6) | 139.7 | (0.5) | 139.2 |
Exceptional expenses | (3.2) | |||||
EBITDA* | 136.0 | |||||
Depreciation and amortisation | (18.3) | |||||
Finance and other income and expenses* | 9.7 | |||||
Profit before tax | 127.4 |
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
| Investments: | ||
Private Equity | 260.9 | 241.3 |
Private Equity - other investments | 7.5 | – |
Private Credit (assets attributable to the Group) | 121.6 | 76.9 |
Private Credit (CLO assets attributable to third-party investors) | 1,267.7 | 696.1 |
Total investments | 1,657.7 | 1,014.3 |
| Carried interest receivable: | ||
Private Equity | 64.7 | 39.4 |
Private Credit | 2.6 | 2.6 |
Total carried interest receivable | 67.3 | 42.0 |
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
Management and other fees before settlement of foreign exchange hedges | 264.2 | 239.1 |
Settlement of foreign exchange hedges | 1.1 | 2.4 |
Total management and other fees | 265.3 | 241.5 |
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
Fair value remeasurement of investments before remeasurement of foreign exchange hedges | 23.8 | 47.0 |
Remeasurement of foreign exchange hedges | 1.5 | (6.3) |
Fair value remeasurement of investments | 25.3 | 40.7 |
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
CLO investment income | 66.7 | 14.9 |
CLO investment expense | (58.5) | (13.0) |
CLO investment income, net | 8.2 | 1.9 |
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
Wages and bonuses | 95.7 | 97.6 |
Social security | 19.2 | 16.1 |
Pensions | 1.9 | 2.0 |
Share-based payments | 4.5 | 0.4 |
Other employee expenses | 11.2 | 10.8 |
Total personnel expenses | 132.5 | 126.9 |
A3 Share Award | A3 Share Award (£ per share) | |||
Group and Company | 2023 | 2022 | 2023 | 2022 |
Opening | 528,975 | 602,000 | 3.96 | 3.96 |
Vested | (56,550) | (60,200) | 3.96 | 3.96 |
Forfeited | (32,025) | (12,825) | 3.96 | 3.96 |
Outstanding at year end | 440,400 | 528,975 | 3.96 | 3.96 |
| Weighted average fair value | ||||
| Number of shares | per share granted (£) | |||
| Group and Company | 2023 | 2022 | 2023 | 2022 |
Rights outstanding at beginning of the period | – | – | N/A | N/A |
Granted | 2,619,773 | – | 2.15 | – |
Granted - dividend equivalents | 75,571 | – | 2.17 | – |
Forfeited | (91,298) | – | 2.17 | – |
Forfeited - dividend equivalents | (1,225) | – | 2.17 | – |
Vested | (730,302) | – | 2.17 | – |
Vested - dividend equivalents | (13,171) | – | 2.17 | – |
Rights outstanding (unvested) at the end of the period | 1,859,348 | – | 2.14 | – |
| Group | ||
| 2023 | 2022 | |
| No. | No. | |
UK | 226 | 221 |
Other | 152 | 145 |
Total | 378 | 366 |
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
| Audit fees | ||
Fees payable to the external auditor for the audit of the Company and the consolidated financial statements | 0.5 | 0.5 |
Fees payable to the external auditor for the audit of the accounts of the Company’s consolidated subsidiaries | 0.9 | 0.9 |
Total audit fees | 1.4 | 1.4 |
| Non-audit fees | ||
Audit-related assurance services | 0.2 | 0.2 |
Other non-audit services | 0.3 | – |
Total non-audit fees | 0.5 | 0.2 |
Total auditor’s remuneration | 1.9 | 1.6 |
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
| Expense relating to low-value asset leases | ||
Low-value asset leases | 0.4 | 0.3 |
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
Personnel expenses | (0.9) | (1.1) |
Other operating expenses | (46.8) | (2.1) |
Total exceptional expenses within EBITDA | (47.7) | (3.2) |
Finance and other expenses | – | – |
Total exceptional expenses | (47.7) | (3.2) |
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
Finance and other income | 6.9 | 13.6 |
Total exceptional income | 6.9 | 13.6 |
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
Depreciation on property, plant and equipment | 14.9 | 15.3 |
Amortisation of intangible assets | 3.8 | 3.0 |
Total depreciation and amortisation expense | 18.7 | 18.3 |
| Group | ||
| (Restated) | ||
| 2023 | 2022 | |
| £ m | £ m | |
Interest income on term deposits | 9.0 | 2.3 |
Finance income on subleases | 0.7 | 0.6 |
| Net foreign exchange gains | – | 1.1 |
| Finance income on amounts receivable from related party investors | 0.1 | – |
Other income | 6.9 | 13.6 |
Total finance and other income | 16.7 | 17.6 |
Interest expense on bank overdrafts and borrowings | (1.8) | (1.3) |
Interest expense on lease liabilities | (3.5) | (3.4) |
Net foreign exchange losses | (2.4) | – |
Finance expense on amounts payable to related party investors | (0.4) | (2.3) |
Other expenses | (1.0) | (0.9) |
Total finance and other expenses | (9.1) | (7.9) |
Net finance and other income, including exceptional items | 7.6 | 9.7 |
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
| Current taxation | ||
Current tax – current year | 3.2 | 3.4 |
Current tax – prior year | (0.2) | 0.4 |
Total current tax expense | 3.0 | 3.8 |
| Deferred tax | ||
Deferred tax – current year | 14.9 | 4.7 |
Deferred tax – prior year | (2.6) | (1.7) |
Total deferred tax expense | 12.3 | 3.0 |
Total tax expense for the year | 15.3 | 6.8 |
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
Profit before tax | 86.0 | 127.4 |
Tax on profit before taxation at the standard rate of corporation tax in the UK of 23.5% (2022: 19.0%) | 20.2 | 24.2 |
Non-taxable and non-deductible items | 11.4 | (23.7) |
Adjustments regarding management fee income and investments | (16.2) | 2.5 |
Effect of foreign tax rates | (1.1) | 0.2 |
Deferred tax not recognised | 3.8 | 5.0 |
Prior year adjustment | (2.8) | (1.4) |
Total tax expense for the year | 15.3 | 6.8 |
| Group | ||
| 2023 | 2022 | |
| £m | £m | |
Tax on amounts recognised in other comprehensive income | (2.2) | 3.3 |
| Group | ||
2023 | 2022 | |
Profit attributable to equity holders of the Company (£ m) | 70.7 | 120.6 |
Weighted average number of ordinary shares for purposes of basic and diluted EPS (m) | 808.5 | 823.3 |
Basic and diluted earnings per share (£) | 0.09 | 0.15 |
| Group | ||||
| Computers, | ||||
| Right-of-use | Leasehold | furniture and | ||
| assets | improvements | other | Total | |
| £ m | £ m | £ m | £ m | |
| Cost | ||||
Balance at 1 January 2023 | 73.1 | 29.8 | 10.5 | 113.4 |
Foreign exchange | – | (0.2) | (0.1) | (0.3) |
Additions | 5.0 | 0.9 | 2.3 | 8.2 |
Disposals | (6.2) | (0.3) | (0.7) | (7.2) |
Balance at 31 December 2023 | 71.9 | 30.2 | 12.0 | 114.1 |
| Accumulated depreciation | ||||
Balance at 1 January 2023 | (17.6) | (4.2) | (6.1) | (27.9) |
Foreign exchange | – | 0.1 | 0.1 | 0.2 |
Depreciation | (9.6) | (3.4) | (1.9) | (14.9) |
Disposals | 1.2 | 0.3 | 0.7 | 2.2 |
Balance at 31 December 2023 | (26.0) | (7.2) | (7.2) | (40.4) |
Carrying value at 31 December 2023 | 45.9 | 23.0 | 4.8 | 73.7 |
| Group | ||||
| Computers, | ||||
| Right-of-use | Leasehold | furniture and | ||
| assets | improvements | other | Total | |
| £ m | £ m | £ m | £ m | |
| Cost | ||||
Balance at 1 January 2022 | 77.4 | 15.2 | 10.8 | 103.4 |
Foreign exchange | – | 0.4 | 0.1 | 0.5 |
Additions | 3.4 | 18.9 | 3.4 | 25.7 |
Disposals | (7.7) | (4.7) | (3.8) | (16.2) |
Balance at 31 December 2022 | 73.1 | 29.8 | 10.5 | 113.4 |
| Accumulated depreciation | ||||
Balance at 1 January 2022 | (14.2) | (5.6) | (7.8) | (27.6) |
Foreign exchange | – | (0.1) | (0.1) | (0.2) |
Depreciation | (10.6) | (2.7) | (2.0) | (15.3) |
Disposals | 7.2 | 4.2 | 3.8 | 15.2 |
Balance at 31 December 2022 | (17.6) | (4.2) | (6.1) | (27.9) |
Carrying value at 31 December 2022 | 55.5 | 25.6 | 4.4 | 85.5 |
| Group | |||
| Customer | |||
| Goodwill | relationship asset | Total | |
| £ m | £ m | £ m | |
| Cost | |||
Balance at 1 January 2023 | 105.1 | 21.2 | 126.3 |
Balance at 31 December 2023 | 105.1 | 21.2 | 126.3 |
| Accumulated amortisation and impairment | |||
Balance at 1 January 2023 | – | (6.7) | (6.7) |
Amortisation | – | (3.0) | (3.0) |
Balance at 31 December 2023 | – | (9.7) | (9.7) |
| Carrying value | |||
Balance at 1 January 2023 | 105.1 | 14.5 | 119.6 |
Balance at 31 December 2023 | 105.1 | 11.5 | 116.6 |
| Group | |||
| Customer | |||
| Goodwill | relationship asset | Total | |
| £ m | £ m | £ m | |
| Cost | |||
Balance at 1 January 2022 | 105.1 | 21.2 | 126.3 |
Balance at 31 December 2022 | 105.1 | 21.2 | 126.3 |
| Accumulated amortisation and impairment | |||
Balance at 1 January 2022 | – | (3.7) | (3.7) |
Amortisation | – | (3.0) | (3.0) |
Balance at 31 December 2022 | – | (6.7) | (6.7) |
| Carrying value | |||
Balance at 1 January 2022 | 105.1 | 17.5 | 122.6 |
Balance at 31 December 2022 | 105.1 | 14.5 | 119.6 |
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
Opening balance | 42.0 | 38.9 |
Income recognised in the year | 29.8 | 23.1 |
Foreign exchange movements recognised as profit or loss | (0.4) | 1.1 |
Foreign exchange movements recognised as other comprehensive income | (0.1) | 0.1 |
Receipts of carried interest | (4.0) | (21.2) |
Closing balance | 67.3 | 42.0 |
| Group | |||||
| Fair value | Financial assets | Assets which | |||
| through profit | Hedging | at amortised | are not financial | ||
| or loss | derivatives | cost | assets | Total | |
| As at 31 December 2023 | £ m | £ m | £ m | £ m | £ m |
Fair value of fund investments | 301.4 | – | – | – | 301.4 |
Consolidated CLO assets | 1,313.0 | – | 35.8 | – | 1,348.8 |
Trade and other receivables | – | – | 124.4 | 17.0 | 141.4 |
Derivative financial instruments | – | 6.2 | – | – | 6.2 |
Other investment | – | – | 7.5 | – | 7.5 |
Cash and cash equivalents | – | – | 238.8 | – | 238.8 |
Consolidated CLO cash | – | – | 76.0 | – | 76.0 |
Total | 1,614.4 | 6.2 | 482.5 | 17.0 | 2,120.1 |
| Group | |||||
| Fair value | Financial assets | Assets which are | |||
| through profit | Hedging | at amortised | not financial | ||
| or loss | derivatives | cost | assets | Total | |
| As at 31 December 2022 | £ m | £ m | £ m | £ m | £ m |
Fair value of fund investments | 273.0 | – | – | – | 273.0 |
Consolidated CLO assets | 726.3 | – | 15.0 | – | 741.3 |
Trade and other receivables | – | – | 181.6 | 23.2 | 204.8 |
Derivative financial instruments | – | 1.0 | – | – | 1.0 |
Cash and cash equivalents | – | – | 196.0 | – | 196.0 |
Term deposits with original maturities of more than three months | – | – | 100.0 | – | 100.0 |
Consolidated CLO cash | – | – | 24.6 | – | 24.6 |
Total | 999.3 | 1.0 | 517.2 | 23.2 | 1,540.7 |
| Company | |||||
| Fair value | Financial assets | Assets which | |||
| through profit | Hedging | at amortised | are not financial | ||
| or loss | derivatives | cost | assets | Total | |
| As at 31 December 2023 | £ m | £ m | £ m | £ m | £ m |
Trade and other receivables | – | – | 8.0 | 0.4 | 8.4 |
Cash and cash equivalents | – | – | 139.7 | – | 139.7 |
Derivative financial instruments | – | 3.9 | – | – | 3.9 |
Total | – | 3.9 | 147.7 | 0.4 | 152.0 |
| Company | |||||
| Fair value | Financial assets | Assets which are | |||
| through profit | Hedging | at amortised | not financial | ||
| or loss | derivatives | cost | assets | Total | |
| As at 31 December 2022 | £ m | £ m | £ m | £ m | £ m |
Trade and other receivables | – | – | 20.3 | – | 20.3 |
Cash and cash equivalents | – | – | 114.0 | – | 114.0 |
Term deposits with original maturities of more than three months | – | – | 50.0 | – | 50.0 |
Total | – | – | 184.3 | – | 184.3 |
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
Opening balance | 273.0 | 313.7 |
Additions | 36.3 | 38.5 |
Change in fair value | 18.5 | 32.9 |
Foreign exchange movements recognised in profit or loss | (1.3) | 5.8 |
Foreign exchange movements recognised in other comprehensive income | (5.1) | 8.2 |
Disposals | (20.0) | (126.1) |
Closing balance | 301.4 | 273.0 |
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
Consolidated CLO assets held by the Group | 1,424.8 | 765.9 |
Consolidated CLO assets attributable to third-party investors | (1,343.7) | (720.7) |
Group’s exposure to consolidated CLO assets | 81.1 | 45.2 |
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
| Derivative financial assets | ||
Forward contracts | 2.3 | 1.0 |
Foreign currency options | 3.9 | – |
Total derivative financial assets | 6.2 | 1.0 |
Group | Company | |||
| 2023 | 2022 | 2023 | 2022 | |
| £ m | £ m | £ m | £ m | |
| Non-current | ||||
Prepayments | 1.7 | 1.6 | – | – |
Trade and other receivables | 21.5 | 18.3 | – | – |
23.2 | 19.9 | – | – | |
| Current | ||||
Trade receivables | 17.5 | 12.2 | 4.7 | – |
Accrued income | 20.6 | 19.0 | – | – |
Prepayments | 11.4 | 6.2 | – | – |
Deferred investment receipts | – | 52.8 | – | – |
Other receivables | 68.7 | 94.7 | 3.7 | 20.3 |
118.2 | 184.9 | 8.4 | 20.3 | |
Total trade and other receivables | 141.4 | 204.8 | 8.4 | 20.3 |
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
Opening balance | 2.8 | 0.1 |
Additions | 4.0 | 3.6 |
Amortisation | (1.9) | (0.9) |
Closing balance | 4.9 | 2.8 |
| Group | ||
| 2023 | 2022 | |
| Lease receivables | £ m | £ m |
Due within 1 year | 3.1 | 2.5 |
Due between 1 and 2 years | 3.6 | 2.5 |
Due between 2 and 3 years | 3.6 | 2.5 |
Due between 3 and 4 years | 3.6 | 2.5 |
Due between 4 and 5 years | 2.0 | 2.5 |
Due after more than 5 years | 6.0 | 5.2 |
Total undiscounted lease payments receivables | 21.9 | 17.7 |
Unearned finance income | (3.4) | (2.3) |
Net investment in leases | 18.5 | 15.4 |
Current | 2.2 | 2.0 |
Non-current | 16.3 | 13.4 |
18.5 | 15.4 |
Group | Company | |||
| 2023 | 2022 | 2023 | 2022 | |
| £ m | £ m | £ m | £ m | |
Cash at bank and in hand | 67.0 | 78.3 | 4.7 | 1.4 |
Money market funds | 170.9 | 17.7 | 135.0 | 12.6 |
Term deposits with original maturities of less than three months | 0.9 | 100.0 | – | 100.0 |
Total cash and cash equivalents | 238.8 | 196.0 | 139.7 | 114.0 |
Term deposits with original maturities of more than three months | – | 100.0 | – | 50.0 |
Consolidated CLO cash | 76.0 | 24.6 | – | – |
Total cash and term deposits | 314.8 | 320.6 | 139.7 | 164.0 |
| Group | |||||
| Liabilities | |||||
| Fair value | Financial | which are not | |||
| through profit | Hedging | liabilities at | financial | ||
| or loss | derivatives | amortised cost | liabilities | Total | |
| As at 31 December 2023 | £ m | £ m | £ m | £ m | £ m |
Trade and other payables | – | – | 47.6 | 98.0 | 145.6 |
Other financial liabilities | 50.1 | – | – | – | 50.1 |
Lease liabilities | – | – | 81.6 | – | 81.6 |
Derivative financial instruments | – | 1.6 | – | – | 1.6 |
Consolidated CLO liabilities | 1,152.0 | – | 14.9 | – | 1,166.9 |
Consolidated CLO purchases awaiting settlement | – | – | 176.8 | – | 176.8 |
Total | 1,202.1 | 1.6 | 320.9 | 98.0 | 1,622.6 |
| Group | |||||
| Fair value | Financial | Liabilities which | |||
| through profit | Hedging | liabilities at | are not financial | ||
| or loss | derivatives | amortised cost | liabilities | Total | |
| As at 31 December 2022 | £ m | £ m | £ m | £ m | £ m |
Trade and other payables | 16.7 | – | 51.8 | 60.6 | 129.1 |
Other financial liabilities | 49.5 | – | – | – | 49.5 |
Lease liabilities | – | – | 83.2 | – | 83.2 |
Derivative financial instruments | – | 13.2 | – | – | 13.2 |
Consolidated CLO liabilities | 597.5 | – | 2.6 | – | 600.1 |
Consolidated CLO purchases awaiting settlement | – | – | 120.6 | – | 120.6 |
Total | 663.7 | 13.2 | 258.2 | 60.6 | 995.7 |
| Company | |||||
| Liabilities | |||||
| Fair value | Financial | which are not | |||
| through profit | Hedging | liabilities at | financial | ||
| or loss | derivatives | amortised cost | liabilities | Total | |
| As at 31 December 2023 | £ m | £ m | £ m | £ m | £ m |
Trade and other payables | – | – | 112.2 | 19.5 | 131.7 |
Total financial liabilities | – | – | 112.2 | 19.5 | 131.7 |
| Company | |||||
| Fair value | Financial | Liabilities which | |||
| through profit | Hedging | liabilities at | are not financial | ||
| or loss | derivatives | amortised cost | liabilities | Total | |
| As at 31 December 2022 | £ m | £ m | £ m | £ m | £ m |
Trade and other payables | – | – | 1.1 | – | 1.1 |
Total financial liabilities | – | – | 1.1 | – | 1.1 |
| (b) Trade and other payables | ||||
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
| Liabilities held at fair value through profit and loss: | ||
CLO repurchase agreements | 28.5 | 28.1 |
Amount payable to related party investors in Opal Investments LP | 8.4 | 10.0 |
Amount payable to related party investors in intermediate fund holding entities | 13.2 | 11.4 |
Total | 50.1 | 49.5 |
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
Liabilities of CLOs consolidated by the Group (non-current) | 1,152.0 | 597.5 |
Liabilities of CLOs consolidated by the Group (current) | 14.9 | 2.6 |
Total | 1,166.9 | 600.1 |
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
Consolidated CLO purchases awaiting settlement | 176.8 | 120.6 |
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
| Derivative financial liabilities: | ||
Forward contracts | 1.6 | 13.2 |
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
Private equity funds | 257.0 | 255.3 |
Credit funds | 30.3 | 34.4 |
Total commitments | 287.3 | 289.7 |
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
| Lease liabilities | ||
Current | 11.9 | 6.1 |
Non-current | 69.7 | 77.1 |
Total | 81.6 | 83.2 |
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
Increase of 1% | (2.5) | (3.0) |
Decrease of 1% | 2.6 | 3.2 |
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
Interest on lease liability | 3.5 | 3.4 |
2023 | 2022 | |||||||
Group | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total |
| Financial assets | ||||||||
| Fair value of fund | ||||||||
investments | – | – | 301.4 | 301.4 | – | – | 273.0 | 273.0 |
Consolidated CLO assets | – | 1,313.0 | – | 1,313.0 | – | 726.3 | – | 726.3 |
Derivative financial assets | – | 6.2 | – | 6.2 | – | 1.0 | – | 1.0 |
Total | – | 1,319.2 | 301.4 | 1,620.6 | – | 727.3 | 273.0 | 1,000.3 |
| Financial Liabilities | ||||||||
| Deferred contingent | ||||||||
consideration payable | – | – | – | – | – | – | 16.7 | 16.7 |
Other financial liabilities | – | – | 50.1 | 50.1 | – | – | 49.5 | 49.5 |
Consolidated CLO liabilities | – | – | 1,152.0 | 1,152.0 | – | – | 597.5 | 597.5 |
Derivative financial liabilities | – | 1.6 | – | 1.6 | – | 13.2 | – | 13.2 |
Total | – | 1.6 | 1,202.1 | 1,203.7 | – | 13.2 | 663.7 | 676.9 |
2023 | 2022 | |||||||
Company | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total |
| Financial assets | ||||||||
Derivative financial assets | – | 3.9 | – | 3.9 | – | – | – | – |
Total | – | 3.9 | – | 3.9 | – | – | – | – |
| Financial Liabilities | ||||||||
Derivative financial liabilities | – | – | – | – | – | – | – | – |
Total | – | – | – | – | – | – | – | – |
| Group | ||
| 2023 | 2022 | |
| Group | £m | £m |
| Level 3 financial assets at fair value through profit or loss: | ||
Opening balance | 273.0 | 313.7 |
Additions | 36.3 | 38.5 |
Change in fair value | 18.5 | 32.9 |
Foreign exchange movements recognised as profit or loss | (1.3) | 5.8 |
Foreign exchange movements recognised as other comprehensive income | (5.1) | 8.2 |
Disposals | (20.0) | (126.1) |
Transfer (to)/from level 1 or 2 | – | – |
Closing balance | 301.4 | 273.0 |
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
| Movement in CLO liabilities at fair value through profit or loss which are level 3: | ||
Opening balance | 597.5 | 29.7 |
On acquisition | – | 287.9 |
Repayment | (52.6) | – |
Drawn | 582.5 | 52.8 |
Foreign exchange movements | (14.0) | 24.2 |
Change in fair value | 38.6 | (9.0) |
Transfers (to)/from level 1 or 2 | – | 211.9 |
Closing balance | 1,152.0 | 597.5 |
2023 | 2022 | |
| Movement in other financial liabilities at fair value through profit or loss which are level 3 | ||
Opening balance | 21.4 | 9.1 |
Additions | 1.3 | 11.1 |
Change in fair value | 0.5 | 0.3 |
Foreign exchange movements | (0.7) | 0.9 |
Disposals | (0.9) | – |
Transfers (to)/from level 1 or 2 | – | – |
Closing | 21.6 | 21.4 |
| Valuation Approach | |
Earnings | The Group primarily uses an earnings approach where a set of relevant listed companies and precedent transactions are |
| available. | |
| Earnings multiples are applied to the earnings of each portfolio company to determine the enterprise value. The most | |
| common measure of earnings is EBITDA. Earnings are adjusted for non-recurring items and run-rate adjustments to | |
| arrive at maintainable earnings. Earnings are usually obtained from portfolio company management accounts or | |
| forecast/budgeted earnings, as considered appropriate. When selecting earning multiples consideration is given to: | |
| − the original transaction price/entry multiple; | |
| − recent transactions in the same or similar instruments; | |
| − relevant comparable listed company multiples; and | |
| − exit expectations and other company specific factors. | |
| The resulting enterprise value is then adjusted to take into account the capital structure of the portfolio company, | |
| including any assets or liabilities such as cash or debt that should be included. The fund’s share of the value is calculated | |
| by calculating its holding. |
| Valuation Approach | |
| Amortising to | Where a performing loan has been originated is valued based upon its amortised cost. Provided that there are no |
| par method | circumstances which indicate material underperformance or inability of the borrower to pay interest or repay the |
| principal, the valuation of loans that have been originated is determined by apportioning any arrangement fees, similar | |
| fees or discount on a linear basis over the anticipated holding period (which is typically three years). | |
Market price | Where a loan is traded in the market, market prices can be obtained for use in pricing. Market prices can be |
| obtained from third-party market price aggregation services or broker quotes where there is an active market. | |
| The extent to which a market is active will depend on the ‘depth’ of the pricing (being the number of distinct price | |
| quotations available from different sources). Before the use of market pricing, consideration is given to anomalies | |
| or other inaccuracies in market pricing and whether there are other factors that should be considered (for example, | |
| recent transactions). | |
Earnings | Where a loan may be impaired an earnings basis is typically used to determine the enterprise value of the borrower, |
| following which a waterfall approach is used to determine the value of the loan. Where there are circumstances which | |
| indicate there is risk of non-performance of the borrower, the enterprise value of the borrower will typically be | |
| determined in accordance with an earnings methodology (as described above), following which a waterfall approach | |
| is used to determine the value of the loan. | |
| Discounted cash | Where the Group holds an interest in the note of a CLO, a discounted cash flow analysis is used to determine the |
| flows | valuation. Inputs used in the discounted cash flow analysis include discount rates and those used to project the |
| expected cash flows relating to the CLO’s underlying asset portfolio including annual loan default rates and associated | |
| recovery rates, prepayment rates, reinvestment rates and spreads. | |
| Other | Considering the broad array of debt instruments that may be held by the funds, it may be deemed appropriate for |
| approaches | other valuation techniques to be utilised in certain cases. |
Upside case** | 0.9 | |||||||
Downside case** | (0.7) | |||||||
Upside case** | 23.0 | |||||||
Downside case** | (18.5) | |||||||
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
Nominal value of forward trades and swap agreements in pound sterling | 362.7 | 294.2 |
Mark-to-market value at year end | 0.2 | (9.6) |
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
Ineffective portion recognised as profit or loss | – | – |
Effective portion recognised as other comprehensive income | 8.6 | (10.5) |
Reclassified to profit or loss upon settlement of hedges | 1.3 | (5.9) |
| Group | ||
2023 | 2022 | |
Euro denominated investments (€m) | 400.7 | 330.7 |
Borrowings (€m) | – | – |
Investment hedges (€m) | (83.3) | (176.7) |
EUR denominated investments, net (€m) | 317.4 | 154.0 |
+/- 5% sensitivity (£m) impact on profit and net assets | 13.7 | 6.8 |
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
Nominal value of forward trades and swap agreements in pound sterling | 74.7 | 156.7 |
Mark-to-market value at year end | 0.6 | (2.6) |
| Group and the Company | ||
| 2023 | 2022 | |
| £ m | £ m | |
Nominal value of foreign exchange options in pound sterling | 103.3 | – |
Mark-to-market value at year end | 3.9 | – |
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
Ineffective portion recognised as profit or loss | – | – |
Effective portion recognised as cash flow hedge reserve in other comprehensive income | – | – |
Effective portion recognised as time value in other comprehensive income | 0.1 | – |
Reclassified as a basis adjustment | – | – |
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
| (+/-) | (+/-) | |
Increase or decrease of 1% | – | – |
| Group | |||||
| Due within | Due between | Due within | Due more than | ||
| 1 year | 1 and 2 years | 2 and 5 years | 5 years | Total | |
| As at 31 December 2023 | £ m | £ m | £ m | £ m | £ m |
Other financial liabilities | – | 21.6 | – | 29.0 | 50.6 |
Derivative financial liabilities | 1.2 | 0.4 | – | – | 1.6 |
Trade and other payables | 47.6 | – | – | – | 47.6 |
Lease liabilities | 15.0 | 14.1 | 38.7 | 25.7 | 93.5 |
Consolidated CLO liabilities | 96.4 | 63.6 | 1,271.5 | – | 1,431.5 |
Consolidated CLO purchases awaiting settlement | 176.8 | – | – | – | 176.8 |
337.0 | 99.7 | 1,310.2 | 54.7 | 1,801.6 |
| Group | |||||
| Due within | Due between | Due within | Due more than | ||
| 1 year | 1 and 2 years | 2 and 5 years | 5 years | Total | |
| As at 31 December 2022 | £ m | £ m | £ m | £ m | £ m |
Other financial liabilities | – | 21.4 | – | 29.7 | 51.1 |
Derivative financial liabilities | 5.2 | 4.8 | 3.2 | – | 13.2 |
Trade and other payables | 51.8 | – | – | – | 51.8 |
Deferred contingent consideration | 16.7 | – | – | – | 16.7 |
Lease liabilities | 9.4 | 13.6 | 39.7 | 34.9 | 97.6 |
Consolidated CLO liabilities | 84.5 | 48.3 | 397.2 | 249.5 | 779.5 |
Consolidated CLO purchases awaiting settlement | 120.6 | – | – | – | 120.6 |
288.2 | 88.1 | 440.1 | 314.1 | 1,130.5 |
| Company | |||||
| Due within | Due between | Due within | Due more than | ||
| 1 year | 1 and 2 years | 2 and 5 years | 5 years | Total | |
| £ m | £ m | £ m | £ m | £ m | |
Trade and other payables | 131.7 | – | – | – | 131.7 |
| Company | |||||
| Due within | Due between | Due within | Due more than | ||
| 1 year | 1 and 2 years | 2 and 5 years | 5 years | Total | |
| As at 31 December 2022 | £ m | £ m | £ m | £ m | £ m |
Trade and other payables | 1.1 | – | – | – | 1.1 |
1.1 | – | – | – | 1.1 |
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
Cash and cash equivalents (for use within the Group) | 238.8 | 196.0 |
Term deposits with original maturities of more than three months | – | 100.0 |
Net cash | 238.8 | 296.0 |
Share capital | 0.1 | 0.1 |
Share premium | 289.8 | 289.8 |
Capital redemption reserve | 0.0 | – |
Share-based payment reserve | 3.0 | 3.6 |
Cash flow hedge reserve | 0.9 | (8.9) |
Foreign exchange option time value reserve | 0.1 | – |
Net exchange differences reserve | 8.6 | 14.4 |
Retained earnings | 418.7 | 473.7 |
Equity attributable to equity holders | 721.2 | 772.7 |
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
Deferred tax assets | 74.6 | 57.9 |
Deferred tax liabilities | (108.5) | (77.3) |
Net deferred tax liability | (33.9) | (19.4) |
| Other timing | Management | Losses carried | ||
| Deferred tax assets | differences | fee hedges | forward | Total |
As at 1 January 2022 | 22.8 | – | 25.0 | 47.8 |
Credit to other comprehensive income | – | 2.0 | – | 2.0 |
(Charge)/credit to the Consolidated Statement of Profit or Loss | (0.3) | – | 8.4 | 8.1 |
As at 31 December 2022 | 22.5 | 2.0 | 33.4 | 57.9 |
(Charge) to other comprehensive income | – | (2.0) | – | (2.0) |
Credit to the Consolidated Statement of Profit or Loss | 2.1 | – | 16.6 | 18.7 |
As at 31 December 2023 | 24.6 | – | 50.0 | 74.6 |
| Management | |||||
| Other timing | Management | fee income and | Capital | ||
| Deferred tax liabilities | differences | fee hedges | investments | allowance | Total |
As at 1 January 2022 | (20.9) | (1.3) | (42.8) | (2.5) | (67.5) |
Credit to other comprehensive income | – | 1.3 | – | – | 1.3 |
Credit/(charge) to the Consolidated Statement of Profit or Loss | 1.9 | – | (10.8) | (2.2) | (11.1) |
As at 31 December 2022 | (19.0) | – | (53.6) | (4.7) | (77.3) |
(Charge) to other comprehensive income | – | (0.2) | – | – | (0.2) |
Credit/(charge) to the Consolidated Statement of Profit or Loss | 4.7 | – | (37.4) | 1.7 | (31.0) |
As at 31 December 2023 | (14.3) | (0.2) | (91.0) | (3.0) | (108.5) |
| Company | ||||
2023 | 2022 | |||
No. | £ | No. | £ | |
Ordinary of £0.00005 each | 794,637,730 | 39,732 | 823,268,774 | 41,163 |
Deferred of £81 each | 500 | 40,500 | 500 | 40,500 |
Deferred of £1 each | 1 | 1 | 1 | 1 |
Deferred of £0.01 each | 1 | 1 | 1 | 0.01 |
Total | 794,638,232 | 80,234 | 823,269,276 | 81,664 |
Group | Company | |||
| 2023 | 2022 | 2023 | 2022 | |
| £ m | £ m | £ m | £ m | |
Cash flow hedge reserve | 0.9 | (8.9) | – | – |
Foreign exchange option time value reserve | 0.1 | – | 0.1 | – |
Net exchange differences reserve | 8.6 | 14.4 | – | – |
Share-based payment reserve | 3.0 | 3.6 | 2.9 | 3.6 |
Merger reserve | – | – | 571.4 | 571.4 |
Capital redemption reserve | 0.0 | – | – | – |
Total | 12.6 | 9.1 | 574.4 | 575.0 |
| Company | ||||
2023 | 2022 | |||
Ordinary dividends | £ m | Pence per share | £ m | Pence per share |
Prior interim dividends paid | 35.3 | 32.8 | ||
Proposed final dividends | 34.9 | 33.0 |
Group | Company | |||
| 2023 | 2022 | 2023 | 2022 | |
| £ m | £ m | £ m | £ m | |
Profit/(loss) before tax | 86.0 | 127.4 | (34.6) | 2.9 |
| Adjustments for: | ||||
Exceptional expenses | 3.3 | 3.2 | – | 0.1 |
Share-based payments | 4.2 | 0.4 | – | – |
Loss on disposal of right-of-use asset | 1.2 | 0.4 | – | – |
Depreciation and amortisation expense | 17.5 | 18.3 | – | – |
Net other income | (10.0) | (8.6) | (2.7) | (1.7) |
Carried interest | (30.0) | (24.2) | – | – |
Fair value remeasurement of investments | (25.3) | (40.7) | – | – |
Net exchange losses/(gains) | 2.4 | (1.1) | 3.4 | 0.1 |
(Increase)/decrease in trade and other receivables | (5.6) | (46.4) | 117.3 | 86.9 |
Increase/(decrease) in trade and other payables | 56.0 | 6.9 | 23.8 | (22.0) |
Cash generated from operations | 99.7 | 35.6 | 107.2 | 66.3 |
| (b) Cash outflows from leases | ||
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
Financing | 10.1 | 7.6 |
Operating | 0.3 | 0.3 |
Cash outflows from leases | 10.4 | 7.9 |
| Group | ||||||
| Foreign | ||||||
| Net additions/ | Fair value | exchange | 31 December | |||
| 1 January 2023 | Cash flows | (disposals) | movements | movements | 2023 | |
| £ m | £ m | £ m | £ m | £ m | £ m | |
Borrowings | – | – | – | – | – | – |
Fair value of consolidated CLO liabilities | 597.5 | – | 529.9 | 38.6 | (14.0) | 1,152.0 |
Lease liabilities | 83.2 | (10.1) | 8.5 | – | – | 81.6 |
Total | 680.7 | (10.1) | 538.4 | 38.6 | (14.0) | 1,233.6 |
| Group | ||||||
| Foreign | ||||||
| Net additions/ | Fair value | exchange | 31 December | |||
| 1 January 2022 | Cash flows | (disposals) | movements | movements | 2022 | |
| £ m | £ m | £ m | £ m | £ m | £ m | |
Borrowings | – | – | – | – | – | – |
Fair value of consolidated CLO liabilities | 241.4 | – | 340.7 | (9.0) | 24.2 | 597.5 |
Lease liabilities | 84.8 | (7.6) | 6.0 | – | – | 83.2 |
Total | 326.2 | (7.6) | 346.7 | (9.0) | 24.2 | 680.7 |
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
Salary, bonus and other benefits | 1.9 | 1.6 |
Total | 1.9 | 1.6 |
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
Salary, bonus and other benefits | 2.4 | 2.1 |
Total | 2.4 | 2.1 |
| Group | ||
| 2023 | 2022 | |
| £ m | £ m | |
Amounts received from funds | 298.2 | 264.3 |
Amounts paid on behalf of the funds | 28.4 | 19.0 |
Amounts receivable from funds | 41.2 | 49.7 |
| Company | ||
| 2023 | 2022 | |
| £ m | £ m | |
Balance as at 1 January | 1,023.0 | 1,022.6 |
Increase in investment in subsidiary and other Group affiliates | 3.9 | 0.4 |
At 31 December | 1,026.9 | 1,023.0 |
| Company’s | |||||
| proportion of | |||||
| Country of | ownership | ||||
Name of subsidiary | Ref | incorporation | Principal activity | Share class | interest |
Bridgepoint Group Holdings Limited | 1 | UK | Holding company | Ordinary shares | 100% |
| Company’s | ||||||
| proportion of | ||||||
| Country of | ownership | |||||
Name of subsidiary | Ref | incorporation | Principal activity | Share class | interest | |
101 | Investments (GP) Limited | 1 | UK | General Partner | Ordinary shares | 100% |
Atlantic GP 1 Limited | 1 | UK | General Partner | Ordinary shares | 100% | |
Atlantic GP 2 Limited | 1 | UK | General Partner | Ordinary shares | 100% | |
Atlantic GP LLP | 1 | UK | General Partner | N/A | – | |
BBTPS GP Limited | 1 | UK | General Partner | Ordinary shares | 100% | |
BBTPS FP GP Limited | 2 | UK | General Partner | Ordinary shares | 100% | |
BBTPS Nominees Limited | 1 | UK | Nominee company | Ordinary shares | 100% | |
BC II FP Limited | 1 | UK | Dormant entity | Ordinary shares | 100% | |
BC II FP SGP Limited | 2 | UK | General Partner | Ordinary shares | 100% | |
BC GP 1 Limited | 1 | UK | General Partner | Ordinary shares | 100% | |
BC GP 2 Limited | 1 | UK | General Partner | Ordinary shares | 100% | |
BC II GP LLP | 2 | UK | General Partner | N/A | – | |
BC II GP LP | 2 | UK | General Partner | N/A | – | |
BC II MLP Limited | 1 | UK | Managing Limited Partner | Ordinary shares | 100% | |
BC MLP UK Limited | 1 | UK | Managing Limited Partner | Ordinary shares | 100% | |
BC SMA Carry GP S.à r.l. | 3 | Luxembourg | General Partner | Ordinary shares | 100% | |
BC SMA II Carry GP LLP | 2 | UK | General Partner | N/A | – | |
BC SMA II FP Limited | 1 | UK | Limited Partner | Ordinary shares | 100% | |
BCLO Credit Investments I S.à r.l. | 3 | Luxembourg | CLO management company | Ordinary shares | 100% | |
BCO II Carry GP LLP | 2 | UK | General Partner | N/A | – | |
BCO III Carry GP LLP | 2 | UK | General Partner | N/A | – | |
BCO IV Carry GP LLP | 2 | UK | General Partner | N/A | – | |
BCO IV FP Limited | 1 | UK | Limited Partner | Ordinary shares | 100% | |
BCO IV LORAC Limited | 1 | UK | Dormant entity | Ordinary shares | 100% | |
BDC GP LP | 2 | UK | General Partner | N/A | – | |
BDC II (SGP) Limited | 2 | UK | General Partner | Ordinary shares | 100% | |
BDC II FP GP Limited | 2 | UK | General Partner | Ordinary shares | 100% | |
BDC II GP LP | 2 | UK | General Partner | N/A | – | |
BDC II Limited | 1 | UK | Limited Partner | Ordinary shares | 100% | |
BDC II Nominees Limited | 1 | UK | Nominee company | Ordinary shares | 100% | |
BDC III GP 1 Limited | 1 | UK | General Partner | Ordinary shares | 100% | |
BDC III GP 2 Limited | 1 | UK | General Partner | Ordinary shares | 100% | |
BDC III GP LLP | 1 | UK | General Partner | N/A | – | |
BDC III Limited | 1 | UK | Limited Partner | Ordinary shares | 100% | |
BDC III Nominees Limited | 1 | UK | Nominee company | Ordinary shares | 100% | |
BDC III SFP GP Limited | 2 | UK | General Partner | Ordinary shares | 100% | |
BDC IV Nominees Limited | 1 | UK | Nominee company | Ordinary shares | 100% | |
BDC IV Limited | 1 | UK | Dormant entity | Ordinary shares | 100% | |
BDC GP 1 Limited | 1 | UK | General Partner | Ordinary shares | 100% | |
BDC IV GP 2 Limited | 1 | UK | General Partner | Ordinary shares | 100% | |
BDC IV MLP Limited | 1 | UK | Managing Limited Partner | Ordinary shares | 100% | |
BDC IV GP LLP | 2 | UK | General Partner | N/A | – | |
BDC IV GP LP | 2 | UK | General Partner | N/A | – | |
| BDC IV SFP GP Limited | 2 | UK | General Partner | Ordinary shares | 100% | |
| BDC V GP LLP | 1 | UK | General Partner | N/A | – | |
| BDC V MLP Limited | 1 | UK | Managing Limited Partner | Ordinary shares | 100% | |
| BDC V GP SCSp | 3 | Luxembourg | General Partner | N/A | – |
| Company’s | |||||
| proportion of | |||||
| Country of | ownership | ||||
Name of subsidiary | Ref | incorporation | Principal activity | Share class | interest |
| BDC V GP 2 Limited | 1 | UK | General Partner | Ordinary shares | 100% |
| BDC Special 1 Limited | 2 | UK | General Partner | Ordinary shares | 100% |
BDC Special 2 Limited | 2 | UK | General Partner | Ordinary shares | 100% |
BDC Special GP LLP | 2 | UK | General Partner | N/A | – |
BDCP II (Nominees) Limited | 1 | UK | Nominee company | Ordinary shares | 100% |
BDCP II GP 1 Limited | 1 | UK | General Partner | Ordinary shares | 100% |
BDCP II GP 2 Limited | 1 | UK | General Partner | Ordinary shares | 100% |
BDCP II GP LLP | 2 | UK | General Partner | N/A | – |
BDCP II GP LP | 2 | UK | General Partner | N/A | – |
BDCP II Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
BDCP II MLP Limited | 1 | UK | Managing Limited Partner | Ordinary shares | 100% |
BDCP II SFP GP Limited | 2 | UK | General Partner | Ordinary shares | 100% |
BDL I Carry GP LLP | 2 | UK | General Partner | N/A | – |
BDL II Carry GP S.à r.l. | 3 | Luxembourg | General Partner | Ordinary shares | 100% |
BDL III Carry GP LLP | 2 | UK | General Partner | N/A | – |
BDL III FP Limited | 1 | UK | Limited Partner | Ordinary shares | 100% |
BDL III LORAC Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
BEP IV (Nominees) Limited | 1 | UK | Nominee company | Ordinary shares | 100% |
BEP IV FP Limited | 1 | UK | Limited Partner | Ordinary shares | 100% |
BEP IV FP SGP Limited | 2 | UK | General Partner | Ordinary shares | 100% |
BEP IV GP 2 Limited | 1 | UK | General Partner | Ordinary shares | 100% |
BEP IV GP LLP | 2 | UK | General Partner | N/A | – |
BEP IV GP LP | 2 | UK | General Partner | N/A | – |
BEP IV MLP Limited | 1 | UK | Managing Limited Partner | Ordinary shares | 100% |
BEV Germany GP Co Limited | 4 | Guernsey | General Partner | Ordinary shares | 100% |
BEV FP Limited | 1 | UK | Limited Partner | Ordinary shares | 100% |
BEV GP LLP | 1 | UK | General Partner | N/A | – |
BEV FP SGP Limited | 2 | UK | General Partner | Ordinary shares | 100% |
BEV GP 2 Limited | 1 | UK | General Partner | Ordinary shares | 100% |
BEV GPC Limited | 1 | UK | General Partner | Ordinary shares | 100% |
BEV MLP Limited | 1 | UK | Managing Limited Partner | Ordinary shares | 100% |
BEV Nominees Limited | 1 | UK | Nominee company | Ordinary shares | 100% |
BEV Nominees II Limited | 1 | UK | Nominee company | Ordinary shares | 100% |
BE VI FP Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
BE VI FP SGP Limited | 2 | UK | General Partner | Ordinary shares | 100% |
BE VI GP 2 Limited | 1 | UK | General Partner | Ordinary shares | 100% |
BE VI GP LLP | 2 | UK | General Partner | N/A | – |
BE VI GP LP | 2 | UK | General Partner | N/A | – |
BE VI MLP Limited | 1 | UK | Managing Limited Partner | Ordinary shares | 100% |
BE VI Nominees Limited | 1 | UK | Nominee company | Ordinary shares | 100% |
| BE VI Nominees II Limited | 1 | UK | Nominee company | Ordinary Shares | 100% |
| BE VII GP SCSp | 3 | Luxembourg | General Partner | N/A | – |
BG II GP LLP | 1 | UK | General Partner | N/A | – |
| BG II Nominees Limited | 1 | UK | Nominee company | Ordinary shares | 100% |
| Bridgepoint Advisers Singapore Pte. Ltd | 16 | Singapore | Private equity advisory company | Ordinary shares | 100% |
Bridgepoint AB | 5 | Sweden | Private equity advisory company | Ordinary shares | 100% |
Bridgepoint Advantage Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
| Company’s | |||||
| proportion | |||||
| Country of | of ownership | ||||
Name of subsidiary | Ref | incorporation | Principal activity | Share class | interest |
Bridgepoint Advantage MLP Limited | 1 | UK | Managing Limited Partner | Ordinary shares | 100% |
Bridgepoint Advantage FP Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
Bridgepoint Advantage FP SGP Limited | 2 | UK | General Partner | Ordinary shares | 100% |
Bridgepoint Advantage GP 2 Limited | 1 | UK | General Partner | Ordinary shares | 100% |
Bridgepoint Advantage GP LLP | 2 | UK | General Partner | N/A | – |
Bridgepoint Advantage GP LP | 2 | UK | General Partner | N/A | – |
Bridgepoint Advantage Nominees Limited | 1 | UK | Nominee company | Ordinary shares | 100% |
Bridgepoint Advisers Europe Limited | 1 | UK | Private equity advisory company | Ordinary shares | 100% |
Bridgepoint Advisers Group Limited | 1 | UK | Investment holding company | Ordinary shares | 100% |
Bridgepoint Advisers Holdings | 1 | UK | Investment holding company | Ordinary shares | 100% |
Bridgepoint Advisers II Limited | 1 | UK | Private equity management company | Ordinary shares | 100% |
Bridgepoint Advisers Limited | 1 | UK | Private equity management company | Ordinary shares | 100% |
Bridgepoint Advisers UK Limited | 1 | UK | Private equity management company | Ordinary shares | 100% |
Bridgepoint Capital (Doolittle) Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
Bridgepoint Capital (Nominees) Limited | 1 | UK | Nominee company | Ordinary shares | 100% |
Bridgepoint Capital Directorships Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
Bridgepoint Capital General Partner LP | 2 | UK | General Partner | N/A | – |
Bridgepoint Capital Group Limited Employee Benefit Trust | 1 | UK | Employee Benefit Trust | N/A | – |
Bridgepoint Capital Scottish GP Limited | 2 | UK | General Partner | Ordinary shares | 100% |
Bridgepoint Capital Partners Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
Bridgepoint Capital Verwaltungs GmbH | 6 | Germany | General Partner | Ordinary shares | 100% |
Bridgepoint Credit AD GP S.à r.l. | 3 | Luxembourg | General Partner | Ordinary shares | 100% |
Bridgepoint Credit Advisers UK Limited | 1 | UK | Credit fund advisory company | Ordinary shares | 100% |
Bridgepoint Credit BOCPIF GP S.à r.l. | 3 | Luxembourg | General Partner | Ordinary shares | 100% |
Bridgepoint Credit Carry LP | 2 | UK | Investment holding company | N/A | – |
| Bridgepoint Credit Carry GP LLP | 2 | UK | General Partner | N/A | – |
| Bridgepoint Credit CLO GP S.à r.l. | 3 | Luxembourg | General Partner | Ordinary shares | 100% |
Bridgepoint Credit Co-Invest GP S.à r.l. | 3 | Luxembourg | General Partner | Ordinary shares | 100% |
Bridgepoint Credit Empire GP S.à r.l. | 3 | Luxembourg | General Partner | Ordinary shares | 100% |
Bridgepoint Credit France SAS | 12 | France | Credit fund management company | Ordinary shares | 100% |
Bridgepoint Credit GP Verwaltungs GmbH | 13 | Germany | General Partner | Ordinary shares | 100% |
Bridgepoint Credit Holdings Limited | 1 | UK | Investment holding company | Ordinary shares | 100% |
Bridgepoint Credit Limited | 1 | UK | Credit fund management company | Ordinary shares | 100% |
Bridgepoint Credit Management Limited | 1 | UK | Credit fund management company | Ordinary shares | 100% |
Bridgepoint Credit MSPD GP S.à r.l. | 3 | Luxembourg | General Partner | Ordinary shares | 100% |
Bridgepoint Credit MPD GP S.à r.l. | 3 | Luxembourg | General Partner | Ordinary shares | 100% |
Bridgepoint Credit Nominees Limited | 1 | UK | Nominee company | Ordinary shares | 100% |
Bridgepoint Credit Opportunities II GP Limited | 2 | UK | General Partner | Ordinary shares | 100% |
Bridgepoint Credit Opportunities II GP LP | 2 | UK | General Partner | N/A | – |
Bridgepoint Credit Opportunities II GP GmbH & Co. KG | 13 | Germany | General Partner | N/A | – |
| Company’s | |||||
| proportion of | |||||
| Country of | ownership | ||||
Name of subsidiary | Ref | incorporation | Principal activity | Share class | interest |
Bridgepoint Credit Opportunities III GP LP | 2 | UK | General Partner | N/A | – |
Bridgepoint Credit Opportunities III GP Limited | 2 | UK | General Partner | Ordinary shares | 100% |
Bridgepoint Credit Opportunities IV GP S.à r.l. | 3 | Luxembourg | General Partner | Ordinary shares | 100% |
Bridgepoint Credit Opportunities SICAV GP S.à r.l. | 3 | Luxembourg | General Partner | Ordinary shares | 100% |
Bridgepoint Credit Partners Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
| Bridgepoint Credit PPF GP S.à r.l. | 3 | Luxembourg | General Partner | Ordinary shares | 100% |
| Bridgepoint Credit PS GP S.à r.l. | 3 | Luxembourg | General Partner | Ordinary shares | 100% |
Bridgepoint Credit Services S.à r.l. | 3 | Luxembourg | Credit fund advisory company | Ordinary shares | 100% |
Bridgepoint Credit UK Limited | 1 | UK | Credit fund advisory company | Ordinary shares | 100% |
Bridgepoint Debt Funding Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
Bridgepoint Debt Management Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
Bridgepoint Debt Managers Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
| Bridgepoint Development Capital Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
| Bridgepoint Development Capital V GP S.a r.l. | 3 | Luxembourg | General Partner | Ordinary shares | 100% |
Bridgepoint Direct Lending II GP S.à r.l. | 3 | Luxembourg | General Partner | Ordinary shares | 100% |
| Bridgepoint Direct Lending III GP S.à r.l. | 3 | Luxembourg | General Partner | Ordinary shares | 100% |
| Bridgepoint Direct Lending IV GP S.à r.l. | 3 | Luxembourg | General Partner | Ordinary shares | 100% |
Bridgepoint Europe (SGP) Ltd | 2 | UK | General Partner | Ordinary shares | 100% |
Bridgepoint Europe III FP (GP) Limited | 2 | UK | General Partner | Ordinary shares | 100% |
Bridgepoint Europe III (GP) Limited | 1 | UK | General Partner | Ordinary shares | 100% |
Bridgepoint Europe III GP LP | 2 | UK | General Partner | N/A | – |
Bridgepoint Europe IV (Nominees) 1 Limited | 1 | UK | Nominee entity | Ordinary shares | 100% |
Bridgepoint Europe IV (Nominees) Limited | 1 | UK | Nominee entity | Ordinary shares | 100% |
Bridgepoint Europe IV FP (GP) Limited | 2 | UK | General Partner | Ordinary shares | 100% |
Bridgepoint Europe IV General Partner L.P. | 2 | UK | General Partner | N/A | – |
Bridgepoint Europe IV General Partner ‘F’ L.P. | 2 | UK | General Partner | N/A | – |
Bridgepoint Europe Limited | 1 | UK | Limited Partner | Ordinary shares | 100% |
Bridgepoint Europe Managerial LLP | 1 | UK | Limited Partner | N/A | – |
| Bridgepoint Europe V Finance 1 Limited | 1 | UK | Dormant entity | Ordinary Shares | 100% |
| Bridgepoint Europe V Finance GP LLP | 1 | UK | General Partner | N/A | 100% |
Bridgepoint Europe VII (GP) S.à r.l. | 3 | Luxembourg | General Partner | Ordinary shares | 100% |
Bridgepoint Europe VII FP Limited | 1 | UK | Limited Partner | Ordinary shares | 100% |
Bridgepoint Europe VII FP SGP Limited | 2 | UK | Dormant entity | Ordinary shares | 100% |
Bridgepoint Europe VII GP 2 Limited | 1 | UK | General Partner | Ordinary shares | 100% |
Bridgepoint Europe VII GP LLP | 1 | UK | General Partner | N/A | – |
Bridgepoint Europe VII Nominees Limited | 1 | UK | Nominee company | Ordinary shares | 100% |
Bridgepoint Europe VII MLP Limited | 1 | UK | Managing Limited Partner | Ordinary shares | 100% |
Bridgepoint Finance Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
Bridgepoint Fund Management S.à r.l. | 3 | Luxembourg | Private equity management company | Ordinary Shares | 100% |
Bridgepoint GmbH | 6 | Germany | Private equity advisory company | Ordinary shares | 100% |
Bridgepoint GP2 LLP | 2 | UK | General Partner | N/A | – |
| Bridgepoint Growth I GP LLP | 1 | UK | General Partner | N/A | – |
| BDC V Nominees Limited | 1 | UK | Nominee entity | Ordinary shares | 100% |
Bridgepoint Growth Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
| Company’s | |||||
| proportion of | |||||
| Country of | ownership | ||||
Name of subsidiary | Ref | incorporation | Principal activity | Share class | interest |
Bridgepoint Growth Nominees Limited | 1 | UK | Nominee company | Ordinary shares | 100% |
Bridgepoint Holdco 1 Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
Bridgepoint Holdings Group Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
Bridgepoint Holdings Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
Bridgepoint Infrastructure Advisers Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
Bridgepoint Infrastructure Development Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
Bridgepoint Infrastructure Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
Bridgepoint International Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
| Bridgepoint Investment Consultants (Shanghai) Co Ltd | 8 | China | Private equity advisory company | Ordinary shares | 100% |
| Bridgepoint Loan Fund GP GmbH & Co. KG | 13 | Germany | General Partner | N/A | – |
Bridgepoint Loan Fund GP S.à.r.l. | 3 | Luxembourg | General Partner | Ordinary shares | 100% |
| Bridgepoint Netherlands B.V. | 9 | Netherlands | Private equity advisory company | Ordinary shares | 100% |
| Bridgepoint OP GP Limited | 1 | UK | General Partner | Ordinary shares | 100% |
| Bridgepoint OP LP | 1 | UK | Investment holding partnership | N/A | – |
Bridgepoint Partners Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
| Bridgepoint SAS | 7 | France | Private equity advisory company | Ordinary shares | 100% |
| Bridgepoint Services France SAS | 12 | France | Private equity advisory company | Ordinary shares | 100% |
Bridgepoint Private Equity Group Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
Bridgepoint Private Equity Growth Fund Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
Bridgepoint Private Equity Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
Bridgepoint Property Advisers Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
Bridgepoint Property Development Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
Bridgepoint Real Estate Advisers Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
Bridgepoint Real Estate Development Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
Bridgepoint Real Estate Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
Bridgepoint Real Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
Bridgepoint SA | 10 | Spain | Private equity advisory company | Ordinary shares | 100% |
Bridgepoint Services Sàrl | 3 | Luxembourg | Private equity advisory company | Ordinary shares | 100% |
Bridgepoint Sp Zoo (in liquidation) | 11 | Poland | Private equity advisory company | Ordinary shares | 100% |
Bridgepoint Sp Zoo sp.k (in liquidation) | 11 | Poland | General Partner | N/A | – |
| Bridgepoint Structured Credit Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
| Bridgepoint UK Holdco Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
| Bridgepoint UK Midco Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
| Bridgepoint US Holdings Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
| Bridgepoint US Holdco Limited | 14 | United States | Investment holding company | Ordinary shares | 100% |
| Bridgepoint US Holdco 2 Limited | 14 | United States | Investment holding company | Ordinary shares | 100% |
Bridgepoint Ventures Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
Bridgepoint, LLC | 14 | United States | Private equity advisory company | Ordinary shares | 100% |
Burgundy GP LLP | 1 | UK | General Partner | N/A | – |
Burgundy GP 2 Limited | 1 | UK | General Partner | Ordinary shares | 100% |
GeorgeTown (Nominees) Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
Horninghaven Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
Horningway Limited | 1 | UK | General Partner | Ordinary shares | 100% |
HPE II GP LP | 2 | UK | General Partner | N/A | – |
HPE SGP Limited | 2 | UK | General Partner | Ordinary shares | 100% |
LORAC 5 Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
LORAC 6 Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
| Company’s | |||||
| proportion of | |||||
| Country of | ownership | ||||
Name of subsidiary | Ref | incorporation | Principal activity | Share class | interest |
LORAC BC Co-Investment Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
LORAC BC II Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
LORAC BDC III Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
LORAC BDC IV Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
LORAC BDC Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
LORAC BDCP II Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
LORAC BEP IV Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
LORAC BE VI Co-investment Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
LORAC BG I Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
LORAC Carry BC SMA II Limited | 1 | UK | Investment holding company | Ordinary Shares | 100% |
LORAC Carry BCO IV Limited | 1 | UK | Investment holding company | Ordinary Shares | 100% |
LORAC Carry BDL III Limited | 1 | UK | Investment holding company | Ordinary Shares | 100% |
LORAC Eagle Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
LORAC KITE Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
New HPE II GP LP | 2 | UK | General Partner | N/A | – |
Opal Investments LP | 2 | UK | Investment holding partnership | N/A | – |
PEPCO Services LLP | 1 | UK | Collective purchasing negotiator | N/A | – |
Ruby Investments (UK) Limited | 1 | UK | Dormant entity | Ordinary shares | 100% |
Sapphire Investments (Guernsey) Limited | 4 | Guernsey | Investment holding company | Ordinary shares | 100% |
Throttle Nominees Limited | 1 | UK | Nominee company | Ordinary shares | 100% |
Vigny Advisory | 15 | France | Dormant entity | Ordinary shares | 100% |
Vigny Participation | 15 | France | Dormant entity | Ordinary shares | 100% |
Vigny Holding | 15 | France | Dormant entity | Ordinary shares | 100% |
Ref | Registered office | |
1 | 5 Marble Arch, London, W1H 7EJ, United Kingdom | |
2 | 50 Lothian Road, Festival Square, Edinburgh, EH3 9WJ, Scotland, United Kingdom | |
3 | 6B Rue du Fort Niedergrünewald, Luxembourg, L-2226, Luxembourg | |
4 | 1 Royal Plaza, Royal Avenue, St Peter Port, Guernsey, GY1 2HL, Guernsey | |
5 | Mäster Samuelsgatan 1, S-111 44 Stockholm , Sweden | |
6 | Nextower, Thurn-und-Taxis-Platz 6, 60313 Frankfurt, Germany | |
7 | 21 Avenue Kleber, 75116, Paris, France | |
8 | Unit 2103-05, ONE ICC, No 999 Middle Huaihai Road, Shanghai, Xuhui District, China | |
9 | Paulus Potterstraat 22A, 1071 DA, Amsterdam, Netherlands | |
10 | Calle Rafael Calvo, 39A-4° - 28010 Madrid , Spain | |
11 | ul. Rondo ONZ 1, 00-124, Warsaw, Poland | |
12 | 21 rue La Pérouse, 75116, Paris, France | |
13 | C/O Steigmaier Steuerberatungsgesellschaft mbH, Schleissheimer Str. 12, 85221, Dachau, Germany | |
14 | 251 | Little Falls Drive, City of Wilmington 19808, County of New Castle |
15 | 21 rue La Pérouse, 75017, Paris, France | |
16 | 10 Anson Road, #22-02, International Plaza, Singapore (079903) |
| Country of | Proportion of | ||||
Name of subsidiary: | Ref | incorporation | Principal activity | Share class | ownership interest |
Bridgepoint PE CI Limited | 1 | UK | Investment holding company | Ordinary shares | 49.1% |
Sapphire Sub II A Limited* | 4 | Guernsey | Investment holding company | Ordinary shares | 100% |
Sapphire Sub II B Limited* | 4 | Guernsey | Investment holding company | Ordinary shares | 100% |
Sapphire Sub III A Limited* | 4 | Guernsey | Investment holding company | Ordinary shares | 100% |
Sapphire Sub III B Limited* | 4 | Guernsey | Investment holding company | Ordinary shares | 100% |
Sapphire Sub III C Limited* | 4 | Guernsey | Investment holding company | Ordinary shares | 100% |
Sapphire Sub South Limited* | 4 | Guernsey | Investment holding company | Ordinary shares | 25% |
| Group’s | ||||
| Country of | proportion of | |||
| incorporation | ownership interest | Nature of interest | Periods consolidated | |
| Name of structured entities: | ||||
BE VI (French) Co-Invest LP | United Kingdom | 86.2% | Limited partner | All periods |
BDC IV (French) Co-Investment LP | United Kingdom | 51.9% | Limited partner | All periods |
Bridgepoint CLO 1 DAC | Ireland | 55.2% | Subordinated note in the residual class | All periods |
Bridgepoint CLO 3 DAC | Ireland | 51.0% | Subordinated note in the residual class | All periods |
Bridgepoint CLO IV DAC | Ireland | 61.0% | Subordinated note in the residual class | All periods |
Bridgepoint CLO V DAC | Ireland | 51.8% | Subordinated note in the residual class | Year ended 31 December 2023 |
Bridgepoint CLO VI DAC | Ireland | 50.0% | Warehouse entity | Year ended 31 December 2023 |
Opal Investments LP | United Kingdom | 85.0% | Limited partner | All periods |
Maple Tree VII LP | United Kingdom | 21.7%* | Limited partner | All periods |
| 31 December | ||
| 2023 | 2022 | |
| £ m | £ m | |
Carried interest receivable | 13.6 | – |
Carried interest payable | (13.5) | – |
Net assets | 0.1 | – |
Result for the year | – | – |
Group’s interest in the associate | 35.0% | 35.0% |
| 31 December | ||
| 2023 | 2022 | |
| £ m | £ m | |
Carried interest receivable | 228.1 | 136.4 |
Carried interest payable | (228.0) | (136.2) |
Net assets | 0.1 | 0.2 |
Result for the year | – | – |
Group’s interest in the associate | 25.9% | 25.9% |
| 31 December | ||
| 2023 | 2022 | |
| £ m | £ m | |
Investments at fair value | 35.7 | 39.5 |
Other assets | 2.5 | 3.2 |
Total liabilities | (2.5) | (2.1) |
Net assets | 35.7 | 40.6 |
Profit for the year | 1.9 | 0.7 |
Group’s interest in the associate | 49.7% | 49.7% |
| 31 December | ||
| 2023 | 2022 | |
| £ m | £ m | |
Investments at fair value | 14.5 | 12.4 |
Other assets | 0.1 | 1.5 |
Total liabilities | (0.2) | (0.1) |
Net assets | 14.4 | 13.8 |
Profit for the year | 0.9 | 2.8 |
Group’s interest in the associate | 45.2% | 45.6% |
101 | Investments (GP) Limited | BDC III GP 2 Limited | BDCP II MLP Limited | Bridgepoint Europe III FP (GP) Limited |
Atlantic GP 1 Limited | BDC III Limited | BDCP II SFP GP Limited | Bridgepoint Europe IV FP (GP) Limited | |
Atlantic GP LLP | BDC III SFP GP Limited | BE VI FP SGP Limited | Bridgepoint Europe Managerial LLP | |
BBTPS FP GP Limited | BDC IV MLP Limited | BE VI GP 2 Limited | Bridgepoint Europe VII FP Limited | |
BC GP 2 Limited | BDC IV SFP GP Limited | BE VI MLP Limited | Bridgepoint Europe VII FP SGP Limited | |
BC II FP SGP Limited | BDC Special 1 Limited | BEP IV FP SGP Limited | Bridgepoint Europe VII GP 2 Limited | |
BC II MLP Limited | BDC Special 2 Limited | BEP IV GP 2 Limited | Bridgepoint Europe VII MLP Limited | |
BDC II FP GP Limited | BDC Special GP LLP | BEP IV MLP Limited | Burgundy GP LLP | |
BDC II Limited | BDCP II GP 2 Limited | BEV FP SGP Limited |
| Group | ||||||||||
| Value of the | accrued | Group | ||||||||
| Group’s | Typical | Net asset | Typical | carried | maximum | |||||
| co- | Group | value of the | Management | Typical | Group share | interest | exposure to | |||
| investments | commitment | Total investor | funds at year | fees received | management | Carried interest rate | of carried | receivable | loss at | |
| at year end | to the fund as | commitments | end | by the Group | fee range | % | interest | at year end | year end | |
| at 31 December | £ m | % | £ bn | £ bn | £ m | % | (where applicable) | % | £ m | £ m |
| 2023 | Generally up to | |||||||||
| Private equity | 0.75 to | 20% of profits | Up to | |||||||
funds | 260.9 | <2% | 28.9 | 16.7 | 205.0 | 2.00% | over threshold | 35% | 64.7 | 325.6 |
| Generally up to | ||||||||||
| 0.50 to | 20% of profits | Up to | ||||||||
Credit funds | 121.6 | <9% | 6.9 | 4.4 | 56.5 | 1.75% | over threshold | 35% | 2.6 | 124.2 |
382.5 | 35.8 | 21.1 | 261.5 | 67.3 | 449.8 |
| Group | ||||||||||
| Value of the | accrued | Group | ||||||||
| Group’s | Typical | Net asset | Typical | carried | maximum | |||||
| co- | Group | value of the | Management | Typical | Group share | interest | exposure to | |||
| investments | commitment | Total investor | funds at year | fees received | management | Carried interest rate | of carried | receivable | loss at | |
| at year end | to the fund as | commitments | end | by the Group | fee range | % | interest | at year end | year end | |
| at 31 December | £ m | % | £ bn | £ bn | £ m | % | (where applicable) | % | £ m | £ m |
| 2022 | Generally up to | |||||||||
| Private equity | 0.75 to | 20% of profits | Up to | |||||||
funds | 241.3 | <2% | 28.2 | 15.5 | 179.5 | 2.00% | over threshold | 35% | 39.4 | 280.7 |
| Generally up to | ||||||||||
| 0.50 to | 20% of profits | Up to | ||||||||
Credit funds | 76.9 | <9% | 6.0 | 2.8 | 50.8 | 1.75% | over threshold | 35% | 2.6 | 79.5 |
318.2 | 34.2 | 18.3 | 230.3 | 42.0 | 360.2 |